Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme

Strahlentherapie und Onkologie

Volumn 187, Issue 9, 2011, Pages 548-554

  Guckenberger, Matthias ^a   Mayer, Mario ^a   Buttmann, Mathias ^a   Vince, Giles H ^a   Sweeney, Reinhart A ^a   Flentje, Michael ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Accelerated radiotherapy temozolomide; Glioblastoma multiforme

Indexed keywords

SULFAMETHOXAZOLE; TEMOZOLOMIDE; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NAUSEA AND VOMITING; OVERALL SURVIVAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DACARBAZINE; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; SURVIVAL RATE; YOUNG ADULT;

EID: 80755136630     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-2242-6     Document Type: Article

References (30)

1. Bleehen NM, Stenning SP. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer 1991;64:769-74.
2. Brada M, Sharpe G, Rajan B et al. Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration. Int J Radiat Oncol Biol Phys 1999;43:287-92. (Pubitemid 29091466)
3. Cho KH, Hall WA, Gerbi BJ et al. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys 1999;45:1133-41.
4. Combs SE, Bischof M, Welzel T et al. Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas. J Neurooncol 2008;89:205-10.
5. Combs SE, Wagner J, Bischof M et al. Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens. Int J Radiat Oncol Biol Phys 2008;71:999-1005.
6. Do V, Gebski V, Barton MB. The effect of waiting for radiotherapy for grade III/IV gliomas. Radiother Oncol 2000;57:131-6.
7. Fabrini MG, Perrone F, De Franco L et al. Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas. Strahlenther Onkol 2009;185:524-9.
8. Fokas E, Wacker U, Gross MW et al. Hypofractionated stereotactic reirradiation of recurrent glioblastomas: a beneficial treatment option after highdose radiotherapy? Strahlenther Onkol 2009;185:235-40.
9. Genc M, Zorlu AF, Atahan IL. Accelerated hyperfractionated radiotherapy in supratentorial malignant astrocytomas. Radiother Oncol 2000;56:233-8. (Pubitemid 30601681)
10. Gutin PH, Iwamoto FM, Beal K et al. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 2009;75:156-63.
11. Hegi ME, Diserens AC, Gorlia T et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352:997-1003. (Pubitemid 40349502)
12. Iliadis G, Selviaridis P, Kalogera-Fountzila A et al. The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometric models. Strahlenther Onkol 2009;185:743-50.
13. Irwin C, Hunn M, Purdie G et al. Delay in radiotherapy shortens survival in patients with high grade glioma. J Neurooncol 2007;85:339-43. (Pubitemid 350142524)
14. Lai R, Hershman DL, Doan T, et al. The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme. Neuro Oncol 2010;12:190-8.
15. Leitzen C, Schild HH, Bungart B et al. Prediction of clinical course of glioblastomas by MRI during radiotherapy. Strahlenther Onkol 2010;186:681-6.
16. Lutterbach J, Weigel P, Guttenberger R et al. Accelerated hyperfractionated radiotherapy in 149 patients with glioblastoma multiforme. Radiother Oncol 1999;53:49-52.
17. Matuschek C, Bolke E, Nawatny J et al. Bevacizumab as a treatment option for radiation-induced cerebral necrosis. Strahlenther Onkol 2011;187:135-9.
18. Nieder C, Andratschke N, Wiedenmann N et al. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome? Strahlenther Onkol 2004;180:401-7. (Pubitemid 39207378)
19. Nieder C, Nestle U, Ketter R et al. Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme. Radiat Oncol Investig 1999;7:36-41. (Pubitemid 29078863)
20. Phillips C, Guiney M, Smith J et al. A randomized trial comparing 35Gy in ten fractions with 60Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma. Radiother Oncol 2003;68:23-6. (Pubitemid 37289332)
21. Prados MD, Wara WM, Sneed PK et al. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2001;49:671-7.
22. Roa W, Brasher PM, Bauman G et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 2004;22:1583-8. (Pubitemid 41079795)
23. Roldan GB, Scott JN, McIntyre JB et al. Population-based study of pseudoprogression after chemoradiotherapy in GBM. Can J Neurol Sci 2009;36:617-22.
24. Sanghera P, Perry J, Sahgal A et al. Pseudoprogression following chemoradiotherapy for glioblastoma multiforme. Can J Neurol Sci 2010;37:36-42.
25. Schwer AL, Kavanagh BD, McCammon R et al. Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 2009;73:352-7.
26. Shibamoto Y, Nishimura Y, Tsutsui K et al. Comparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant glioma. Jpn J Clin Oncol 1997;27:31-6. (Pubitemid 127516282)
27. Stupp R, Hegi ME, Mason WP et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:6459-66.
28. Vordermark D, Kolbl O, Ruprecht K et al. Hypofractionated stereotactic reirradiation: treatment option in recurrent malignant glioma. BMC Cancer 2005;5:55.
29. Voynov G, Kaufman S, Hong T et al. Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy. Am J Clin Oncol 2002;25:606-11. (Pubitemid 35453670)
30. Walker MD, Strike TASheline GE An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979;5:1725-31. (Pubitemid 10187518)